Cassava Sciences | PTIE - Aktywa





Aktywa Zmiana Data
Abbott USD 108.25B 968M 2026-09
Amgen USD 96.05B 409M 2026-09
Biogen USD 32.05B 32.5M 2026-09
Cara Therapeutics USD 25.82M 6.26M 2026-03
Cassava Sciences USD 103.9M 4.46M 2026-06
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 148.07B 5.79B 2026-09
Geron USD 527.11M 8.1M 2026-09
J&J USD 197.42B 3.64B 2026-09
Merck USD 132.77B 2.97B 2026-09
Novartis USD 117.15B 4.88B 2026-09
Novavax USD 955.58M 87.59M 2026-06
Pfizer USD 204.54B 3.41B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06